Menopause

Locations

Clinic information

Contact

Outpatients appointments
020 3313 5000
General Enquiries
020 3313 3913

Visitor Information

Google translate Translation help:

To translate this page into your preferred language, click the Google Translate icon in the top-right menu and select your desired language.

Visiting

We have two menopause clinics, the general menopause clinic and the premature menopause clinic, both located at Queen Charlotte’s & Chelsea Hospital.

We provide care for women with routine menopause-related problems and specialised care for women with complex menopause-related gynaecological, medical and hormonal therapy problems.

Our premature menopause service is one of only a few of its kind in the UK, and we are at the forefront of research in this area. All patients (with consent) go onto a national registry to improve their care and that of future patients with premature menopause.

Conditions and treatments

We offer routine and specialised multidisciplinary care, as well as consultations with a psychologist if appropriate. We treat:

  • Menopause
  • Osteoporosis
  • Iatrogenic menopause (for women below the age of 40, medically/surgically induced menopause)
  • Spontaneous premature menopause

Treatments we offer

  • Hormone replacement therapy (HRT) and alternatives
  • Premature menopause services
  • Complementary therapies
  • Pharmacological options and body identical hormone administration
  • Hormone profiles
  • Bone density scans

Additional information

Clinical trials and research

This service is actively involved in clinical trials and you may be offered the opportunity to participate in one at your appointment depending on what trials are active at that time.  Our current research trials in February 2020 include

E4 COMFORT (Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in

Postmenopausal Women) – contact sarahamilton@nhs.net or 020 3313 5281 for more information

SOJOURNIX-653-006 (a phase 2, prospective, randomized, double-blind, Placebo-controlled clinical study to assess the Efficacy, safety, tolerability, and pharmacokinetics of Sjx-653 in postmenopausal women with moderate to Severe vasomotor symptoms) - contact sarahamilton@nhs.net or 020 3313 5281 for more information

OPTIMISE (Comparison of ultra-low-dose Oral versus Transdermal Hormone Therapy on coagulation activation and metabolic risk factors for Cardiovascular Disease – contact Dr Sophia Tsiligiannis on 07562 742055 for more information.

Education

If you are interested in an elective placement with our service, please contact Mr Panay's secretary Sharlene.

Phone: 020 8383 3513

Further online resources